Market Cap 8.66B
Revenue (ttm) 1.20B
Net Income (ttm) 96.70M
EPS (ttm) N/A
PE Ratio 34.42
Forward PE 31.14
Profit Margin 8.06%
Debt to Equity Ratio 0.47
Volume 757,100
Avg Vol 893,540
Day's Range N/A - N/A
Shares Out 86.16M
Stochastic %K 89%
Beta 0.47
Analysts Strong Sell
Price Target $121.78

Company Profile

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It provides health savings accounts; investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. The company also offers flexible spending accounts for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefi...

Industry: Health Information Services
Sector: Healthcare
Phone: 801 727 1000
Fax: 877 353 9236
Address:
15 West Scenic Pointe Drive, Suite 100, Draper, United States
StageAnalysis
StageAnalysis Nov. 15 at 12:38 AM
Stage Analysis Screener – Stage 2 Breakouts & Continuation Breakouts $PGNY, DTM, SMFG, TTE, LAMR, $CNQ, $HQY, CPRX, SOLV, PCVX, TNDM Filters: Stage: 2A, 2, 2B Stage Change: Stage Changed Market Cap: +Mini (over $300MLN) WCR: Close in Upper Quarter of Bar Avg $ Volume: Over 100M Breakout: 13W Breakout – Cross Above 13W High Sort order: SATA Score / Mansfield RS The purpose of this scan is to find stocks attempting to breakout into Stage 2
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:34 AM
$HQY: The last close at $101.77 is near the 60D high of $101.84, indicating potential resistance. The RSI at 65.03 suggests that the stock is nearing overbought territory, which could lead to a pullback. The MA30 at $94.56 and MA50 at $94.02 are significantly lower, indicating strong support levels and a bullish trend in the medium term. However, the proximity to the 60D high and elevated RSI signals caution for new long positions. Directional bias: Neutral to slightly bearish in the short term due to the high RSI and proximity to resistance. Suggested entry: Consider entering a short position if the price breaks below $100.00. Stop: Set a stop-loss at $102.50 to limit potential losses. Targets: First target at $96.00 (MA30 support) and second target at $94.00 (MA50 support). Monitor closely for any reversal signals. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 14 at 1:09 PM
$HQY rolls out cutting-edge agentic AI — what’s the impact? 🤖 The new AI platform, powered by Parloa, enhances member support with natural, conversational interactions, promising to boost retention and cut servicing costs. Despite a flat stock reaction, HQY is up 3.7% YTD compared to an industry decline of 5.5%. 📈 Discover the full implications for HQY here 👉 https://www.zacks.com/stock/news/2791087/healthequity-rolls-out-agentic-ai-to-elevate-member-support-experience?cid=sm-stocktwits-2-2791087-body-21060&ADID=SYND_STOCKTWITS_TWEET_2_2791087_BODY_21060
0 · Reply
ZacksResearch
ZacksResearch Nov. 14 at 12:09 PM
Is $HQY about to level up its whole user experience? The company just rolled out new agentic AI that’s likely to deliver faster, more intuitive support across channels — a clear push to boost member satisfaction. See the full breakdown here 👉 https://www.zacks.com/stock/news/2791087/healthequity-rolls-out-agentic-ai-to-elevate-member-support-experience?cid=sm-stocktwits-2-2791087-teaser-21050&ADID=SYND_STOCKTWITS_TWEET_2_2791087_TEASER_21050
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:07 AM
$HQY: The current market context shows a last close of $99.5, which is above the 30-day moving average (MA30) of $94.12 and the 50-day moving average (MA50) of $93.82, indicating a bullish trend. The RSI at 58.99 suggests that the asset is neither overbought nor oversold, allowing for potential upward movement. The recent price action is within the 60-day high of $101.63 and low of $86.62, providing a favorable range for trading. Directional bias is bullish due to the price being above key moving averages and the RSI indicating strength. Suggested entry: $99.5. Stop loss: $96.5 (below MA30 for protection). Target 1: $101 (near the 60D high). Target 2: $104 (potential resistance level). This plan leverages current momentum while managing risk effectively. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 11:01 AM
BMO Capital updates rating for HealthEquity ( $HQY ) to Market Perform, target set at 100.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:13 AM
$HQY is currently trading at $99.83, above its 30-day moving average (MA30) of $93.47 and 50-day moving average (MA50) of $93.68, indicating bullish momentum. The RSI at 63.56 suggests that the stock is nearing overbought conditions but still has room for further gains. The recent high of $101.59 is a key resistance level, while the low of $86.62 provides a solid support base. Directional bias is bullish due to the price being above both MAs and the proximity to the recent high. Suggested entry could be around $99.00 to capitalize on potential upward movement. A stop loss should be placed at $97.00 to manage risk. Targets can be set at $101.00 (near the 60D high) and $102.50 for a more aggressive approach, considering the stock's upward potential. Overall, the analysis supports a bullish outlook for $HQY with strategic entry and risk management in place. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:50 AM
$HQY is currently trading at $99.83, above its 30-day moving average (MA30) of $93.47 and 50-day moving average (MA50) of $93.68, indicating bullish momentum. The RSI at 63.56 suggests that the stock is nearing overbought conditions but still has room for further gains. The recent high of $101.59 is a key resistance level, while the low of $86.62 provides a solid support base. Directional bias is bullish due to the price being above both MAs and the proximity to the recent high. Suggested entry could be around $99.00 to capitalize on potential upward movement. A stop loss should be placed at $97.00 to manage risk. Targets can be set at $101.00 (near the 60D high) and $102.50 for a more aggressive approach, considering the stock's upward potential. Overall, the analysis supports a bullish outlook for $HQY with strategic entry and risk management in place. https://privateprofiteers.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 6:14 PM
Enter: $HQY NOV 21 2025 $95 CALLS Buy in Price: $4.14 - $4.30 Take Profit: $7.12 Stop Bleeding: $3.64 ROI Potential: 72% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 16 at 5:26 PM
$HQY up 9.5% in 6 months — what’s fueling the momentum? 🚀 ✅ Strong Q2 performance with solid top-line and bottom-line results ⚙️ AI-driven efficiency gains and enhanced digital engagement strategies 📈 Positive EPS estimate revisions for fiscal 2026 However, data security threats remain a concern. Discover why HQY is a Zacks Rank #2 (Buy) here 👉 https://www.zacks.com/stock/news/2770497/reasons-to-add-healthequity-stock-to-your-portfolio-for-now?cid=sm-stocktwits-2-2770497-body-16438&ADID=SYND_STOCKTWITS_TWEET_2_2770497_BODY_16438
0 · Reply
Latest News on HQY
HealthEquity to Enhance Member Experience with Agentic AI

Nov 13, 2025, 9:00 AM EST - 1 day ago

HealthEquity to Enhance Member Experience with Agentic AI


HealthEquity: Swing Trading Stock With A Beat And Raise

Sep 4, 2025, 7:28 AM EDT - 2 months ago

HealthEquity: Swing Trading Stock With A Beat And Raise


HealthEquity, Inc. (HQY) Q2 2026 Earnings Call Transcript

Sep 2, 2025, 7:37 PM EDT - 2 months ago

HealthEquity, Inc. (HQY) Q2 2026 Earnings Call Transcript


HealthEquity Stock Climbs After Q2 Earnings Report: Here's Why

Sep 2, 2025, 4:41 PM EDT - 2 months ago

HealthEquity Stock Climbs After Q2 Earnings Report: Here's Why


The Best Growth Stocks to Buy

Jul 8, 2025, 8:12 AM EDT - 4 months ago

The Best Growth Stocks to Buy

ALGM AMZN AVGO BURL CTRE DAR DXCM


HealthEquity, Inc. (HQY) Q1 2026 Earnings Call Transcript

Jun 4, 2025, 1:36 AM EDT - 5 months ago

HealthEquity, Inc. (HQY) Q1 2026 Earnings Call Transcript


HealthEquity: Shares Near Fair Value After Solid Q1

Jun 4, 2025, 12:56 AM EDT - 5 months ago

HealthEquity: Shares Near Fair Value After Solid Q1


How Will HealthEquity Stock React To Its Upcoming Earnings?

Jun 2, 2025, 10:05 AM EDT - 5 months ago

How Will HealthEquity Stock React To Its Upcoming Earnings?


USA Today Names HealthEquity to its Top 25 Workplaces

Apr 29, 2025, 9:00 AM EDT - 7 months ago

USA Today Names HealthEquity to its Top 25 Workplaces


StageAnalysis
StageAnalysis Nov. 15 at 12:38 AM
Stage Analysis Screener – Stage 2 Breakouts & Continuation Breakouts $PGNY, DTM, SMFG, TTE, LAMR, $CNQ, $HQY, CPRX, SOLV, PCVX, TNDM Filters: Stage: 2A, 2, 2B Stage Change: Stage Changed Market Cap: +Mini (over $300MLN) WCR: Close in Upper Quarter of Bar Avg $ Volume: Over 100M Breakout: 13W Breakout – Cross Above 13W High Sort order: SATA Score / Mansfield RS The purpose of this scan is to find stocks attempting to breakout into Stage 2
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:34 AM
$HQY: The last close at $101.77 is near the 60D high of $101.84, indicating potential resistance. The RSI at 65.03 suggests that the stock is nearing overbought territory, which could lead to a pullback. The MA30 at $94.56 and MA50 at $94.02 are significantly lower, indicating strong support levels and a bullish trend in the medium term. However, the proximity to the 60D high and elevated RSI signals caution for new long positions. Directional bias: Neutral to slightly bearish in the short term due to the high RSI and proximity to resistance. Suggested entry: Consider entering a short position if the price breaks below $100.00. Stop: Set a stop-loss at $102.50 to limit potential losses. Targets: First target at $96.00 (MA30 support) and second target at $94.00 (MA50 support). Monitor closely for any reversal signals. https://privateprofiteers.com
0 · Reply
ZacksResearch
ZacksResearch Nov. 14 at 1:09 PM
$HQY rolls out cutting-edge agentic AI — what’s the impact? 🤖 The new AI platform, powered by Parloa, enhances member support with natural, conversational interactions, promising to boost retention and cut servicing costs. Despite a flat stock reaction, HQY is up 3.7% YTD compared to an industry decline of 5.5%. 📈 Discover the full implications for HQY here 👉 https://www.zacks.com/stock/news/2791087/healthequity-rolls-out-agentic-ai-to-elevate-member-support-experience?cid=sm-stocktwits-2-2791087-body-21060&ADID=SYND_STOCKTWITS_TWEET_2_2791087_BODY_21060
0 · Reply
ZacksResearch
ZacksResearch Nov. 14 at 12:09 PM
Is $HQY about to level up its whole user experience? The company just rolled out new agentic AI that’s likely to deliver faster, more intuitive support across channels — a clear push to boost member satisfaction. See the full breakdown here 👉 https://www.zacks.com/stock/news/2791087/healthequity-rolls-out-agentic-ai-to-elevate-member-support-experience?cid=sm-stocktwits-2-2791087-teaser-21050&ADID=SYND_STOCKTWITS_TWEET_2_2791087_TEASER_21050
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:07 AM
$HQY: The current market context shows a last close of $99.5, which is above the 30-day moving average (MA30) of $94.12 and the 50-day moving average (MA50) of $93.82, indicating a bullish trend. The RSI at 58.99 suggests that the asset is neither overbought nor oversold, allowing for potential upward movement. The recent price action is within the 60-day high of $101.63 and low of $86.62, providing a favorable range for trading. Directional bias is bullish due to the price being above key moving averages and the RSI indicating strength. Suggested entry: $99.5. Stop loss: $96.5 (below MA30 for protection). Target 1: $101 (near the 60D high). Target 2: $104 (potential resistance level). This plan leverages current momentum while managing risk effectively. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 11:01 AM
BMO Capital updates rating for HealthEquity ( $HQY ) to Market Perform, target set at 100.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:13 AM
$HQY is currently trading at $99.83, above its 30-day moving average (MA30) of $93.47 and 50-day moving average (MA50) of $93.68, indicating bullish momentum. The RSI at 63.56 suggests that the stock is nearing overbought conditions but still has room for further gains. The recent high of $101.59 is a key resistance level, while the low of $86.62 provides a solid support base. Directional bias is bullish due to the price being above both MAs and the proximity to the recent high. Suggested entry could be around $99.00 to capitalize on potential upward movement. A stop loss should be placed at $97.00 to manage risk. Targets can be set at $101.00 (near the 60D high) and $102.50 for a more aggressive approach, considering the stock's upward potential. Overall, the analysis supports a bullish outlook for $HQY with strategic entry and risk management in place. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:50 AM
$HQY is currently trading at $99.83, above its 30-day moving average (MA30) of $93.47 and 50-day moving average (MA50) of $93.68, indicating bullish momentum. The RSI at 63.56 suggests that the stock is nearing overbought conditions but still has room for further gains. The recent high of $101.59 is a key resistance level, while the low of $86.62 provides a solid support base. Directional bias is bullish due to the price being above both MAs and the proximity to the recent high. Suggested entry could be around $99.00 to capitalize on potential upward movement. A stop loss should be placed at $97.00 to manage risk. Targets can be set at $101.00 (near the 60D high) and $102.50 for a more aggressive approach, considering the stock's upward potential. Overall, the analysis supports a bullish outlook for $HQY with strategic entry and risk management in place. https://privateprofiteers.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 6:14 PM
Enter: $HQY NOV 21 2025 $95 CALLS Buy in Price: $4.14 - $4.30 Take Profit: $7.12 Stop Bleeding: $3.64 ROI Potential: 72% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 16 at 5:26 PM
$HQY up 9.5% in 6 months — what’s fueling the momentum? 🚀 ✅ Strong Q2 performance with solid top-line and bottom-line results ⚙️ AI-driven efficiency gains and enhanced digital engagement strategies 📈 Positive EPS estimate revisions for fiscal 2026 However, data security threats remain a concern. Discover why HQY is a Zacks Rank #2 (Buy) here 👉 https://www.zacks.com/stock/news/2770497/reasons-to-add-healthequity-stock-to-your-portfolio-for-now?cid=sm-stocktwits-2-2770497-body-16438&ADID=SYND_STOCKTWITS_TWEET_2_2770497_BODY_16438
0 · Reply
ZacksResearch
ZacksResearch Oct. 16 at 4:26 PM
$HQY showing real momentum — is this the next healthcare sleeper? 💪 Strong Q2 results, expanding HSA base, and AI-driven efficiencies are fueling growth, even as data security risks linger. Discover why HealthEquity could be worth a closer look 👉 https://www.zacks.com/stock/news/2770497/reasons-to-add-healthequity-stock-to-your-portfolio-for-now?cid=sm-stocktwits-2-2770497-teaser-16430&ADID=SYND_STOCKTWITS_TWEET_2_2770497_TEASER_16430
0 · Reply
kusti007
kusti007 Oct. 15 at 4:53 AM
$HQY Business Strengths: • Leading provider of HSAs with strong recurring revenue. • Growing demand for tax-advantaged health savings in the U.S. • Recent guidance for FY2026 has been raised, showing management confidence. • Latest quarterly EPS (Q2 FY2026) came in at $1.08, beating expectations. Price targets all higher than 110🚀🚀
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 14 at 2:41 PM
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 6:46 AM
$HQY: Unusual Options Activity Alerted PUT flow observed 200x contracts at Strike price of $80 Exp on 11/21/2025 with Premium of $25K and showing BEARISH Sentiment
0 · Reply
Professler
Professler Oct. 1 at 3:52 PM
$HQY Here is a gem in the rough that I'll keep my eye on. Safety play and one of the fastest growing HSA providers. Margins, revenue, and EPS have all been growing at a healthy rate.
0 · Reply
SweepCastApp
SweepCastApp Sep. 29 at 2:29 PM
$HQY: Unusual Options Activity Alerted PUT flow observed 43x contracts at Strike price of $100 Exp on 11/21/2025 with Premium of $31K and showing BEARISH Sentiment
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 7:18 AM
Enter: $HQY OCT 17 2025 $95 CALLS Buy in Price: $3.15 - $3.80 Take Profit: $5.58 Stop Bleeding: $2.77 ROI Potential: 77% Exit Within: 284 Minutes https://moneygroup.us/alerts
0 · Reply
theresilienttrader
theresilienttrader Sep. 24 at 3:23 PM
$HQY 🚨 Trade Idea: $HQY 🚨 Healthcare costs keep climbing, and HealthEquity is the #1 HSA provider set to benefit. 10M+ HSA accounts $33B in assets Revenue +9% YoY, Net Income +67% YoY Stock trending above key MAs 📊 Playbook: ✅ Buy HQY @ $95.86 ✅ Sell Nov 21 $90 Puts for $2.90 ($290 income/contract) Targets: $100$110 Healthcare costs = pain for consumers, but opportunity for traders. https://www.theresilienttrader.com/p/healthcare-tailwind-powering-healthequity-hqy
0 · Reply
AdamHorabik1081
AdamHorabik1081 Sep. 22 at 7:29 AM
$HQY Healthcare technology growth. Breaking above consolidation. Volume expansion noted. Relative strength.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 19 at 5:13 PM
Enter: $HQY OCT 17 2025 $95 CALLS Buy in Price: $2.33 - $2.70 Take Profit: $3.70 Stop Bleeding: $2.05 ROI Potential: 59% Exit Within: 252 Minutes https://moneygroup.us/alerts
0 · Reply
GammaVibe
GammaVibe Sep. 15 at 9:59 AM
$HQY Emerging-market exposure adds growth but increases FX risk
0 · Reply
Estimize
Estimize Sep. 10 at 8:00 PM
Wall St is expecting 0.91 EPS for $HQY Q3 [Reporting 12/09 AMC] http://www.estimize.com/intro/hqy?chart=historical&metric_name=eps&utm_cont
0 · Reply